Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Author: Avi Kapoor | December 11, 2024 05:27am
Shares of Stitch Fix, Inc. (NASDAQ:SFIX) rose sharply in today's pre-market trading session after the company reported better-than-expected first-quarter EPS and sales.
Stitch Fix reported a quarterly loss of 5 cents per share which beat the analyst consensus estimate of a loss of 13 cents per share. The company reported quarterly sales of $318.80 million which beat the analyst consensus estimate of $306.93 million.
Stitch Fix shares jumped 21.3% to $5.58 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- SEALSQ Corp (NASDAQ:LAES) gained 134.6% to $1.34 in pre-market trading after jumping 46% on Tuesday.
- Silexion Therapeutics Corp (NASDAQ:SLXN) rose 60.2% to $4.36 in pre-market trading. Silexion Therapeutics named renowned cancer therapeutics expert Prof. Amnon Peled to Board of Directors.
- Frequency Electronics, Inc. (NASDAQ:FEIM) gained 48.6% to $19.00 in pre-market trading after the company reported a year-over-year increase in first-quarter financial results.
- CleanCore Solutions, Inc. (NYSE:ZONE) gained 42.2% to $1.82 in pre-market trading.
- MIND Technology, Inc. (NASDAQ:MIND) gained 23.4% to $5.22 in pre-market trading after the company announced better-than-expected quarterly financial results.
- Quantum Corporation (NASDAQ:QMCO) gained 18.7% to $24.00 in pre-market trading after jumping 27% on Tuesday.
- Biofrontera Inc. (NASDAQ:BFRI) climbed 18.5% to $1.41 in pre-market trading.
- SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 15.8% to $0.4070 in pre-market trading after falling 11% on Tuesday.
- Rezolve AI Limited (NASDAQ:RZLV) gained 10.3% to $2.13 in pre-market trading.
Losers
- Q32 Bio Inc. (NASDAQ:QTTB) shares tumbled 67.6% to $7.87 in pre-market trading after the company announced that while its SIGNAL-AD Phase 2a clinical trial in atopic dermatitis showed promising findings in Part A, it did not meet the primary endpoint in Part B.
- Cellectar Biosciences, Inc. (NASDAQ:CLRB) declined 50.7% to $0.6273 in pre-market trading after the company issued strategic update on clinical development, pipeline programs and corporate restructuring.
- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) shares fell 30.4% to $0.2098 in pre-market trading after gaining 6% on Monday.
- American Lithium Corp. (NASDAQ:AMLI) shares fell 24.8% to $0.47 in pre-market trading after the company announced intention to voluntarily delist its common shares from Nasdaq Capital Market
- 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) dipped 23.1% to $1.50 in pre-market trading. 60 Degrees Pharmaceuticals shares are trading jumped around 34% on Tuesday amid a Form 4 filing stating the company chairman purchased 73,951 shares.
- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 21.8% to $1.04 in pre-market trading after gaining over 7% on Tuesday.
- ImmunityBio, Inc. (NASDAQ:IBRX) shares dipped 19.2% to $3.75 in pre-market trading after the company proposed a public offering of common stock.
- Falcon’s Beyond Global, Inc. (NASDAQ:FBYD) fell 18.8% to $9.35 in pre-market trading after jumping over 45% on Tuesday.
- Palmer Square Capital BDC Inc. (NYSE:PSBD) fell 18.1% to $13.00 in pre-market trading.
- Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) fell 15.8% to $30.96 in today's pre-market trading after the company reported worse-than-expected third-quarter EPS and sales results on Tuesday. The company also announced that CEO Chris Morris handed in his resignation to pursue other interests. The board said it has been working with a global executive search firm in recent months to assist in identifying the company’s next permanent CEO.
Now Read This:
Posted In: AMLI BFRI CLRB FBYD FEIM IBRX LAES MIND PCSA PLAY PSBD QMCO QTTB RZLV SFIX SLXN SMX SXTP TFFP ZONE
